Reuben Ramphal

11.6k total citations · 1 hit paper
134 papers, 8.6k citations indexed

About

Reuben Ramphal is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Molecular Medicine. According to data from OpenAlex, Reuben Ramphal has authored 134 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 32 papers in Molecular Medicine. Recurrent topics in Reuben Ramphal's work include Bacterial biofilms and quorum sensing (40 papers), Cystic Fibrosis Research Advances (33 papers) and Antibiotic Resistance in Bacteria (32 papers). Reuben Ramphal is often cited by papers focused on Bacterial biofilms and quorum sensing (40 papers), Cystic Fibrosis Research Advances (33 papers) and Antibiotic Resistance in Bacteria (32 papers). Reuben Ramphal collaborates with scholars based in United States, France and Canada. Reuben Ramphal's co-authors include Shiwani K. Arora, Stephen Lory, Nandini Dasgupta, Jeevan Jyot, Gerald B. Pier, Bruce W. Ritchings, S Vishwanath, Paul G. Ambrose, Parker A. Small and Amrisha Verma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Reuben Ramphal

132 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy

1991 706 citations Reuben Ramphal et al. profile →

Peers

Countries citing papers authored by Reuben Ramphal

Since Specialization

Citations

This map shows the geographic impact of Reuben Ramphal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuben Ramphal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuben Ramphal more than expected).

Fields of papers citing papers by Reuben Ramphal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reuben Ramphal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuben Ramphal. The network helps show where Reuben Ramphal may publish in the future.

Co-authorship network of co-authors of Reuben Ramphal

This figure shows the co-authorship network connecting the top 25 collaborators of Reuben Ramphal. A scholar is included among the top collaborators of Reuben Ramphal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reuben Ramphal. Reuben Ramphal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients 2021 ·PLoS ONE ·Asmita Gupte, Jeevan Jyot, (unknown), Reuben Ramphal	18
2	Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets 2020 ·Journal of Cystic Fibrosis ·Ignacio Caballero, (unknown), Mustapha Si‐Tahar, Pascal Barbry, Antoine Guillon, Isabelle Lantier, Mustapha Berri, Claire Chevaleyre, (unknown), Céline Barc, Reuben Ramphal, Nicolas Pons, Agnès Paquet, Kévin Lebrigand, Carole Baron, Andrea Bähr, Nikolai Klymiuk, Renaud Léonard, Catherine Robbe‐Masselot	14
3	Tracheal Mucosal Damage after Aspiration 2015 ·American Review of Respiratory Disease ·James W. Wynne, Reuben Ramphal, C. Ian Hood	0
4	Flagellin concentrations in expectorations from cystic fibrosis patients 2014 ·BMC Pulmonary Medicine ·Viviane Balloy, Guiti Thévenot, Thierry Bienvenu, P Morand, Harriet Corvol, Annick Clément, Reuben Ramphal, D. Hubert, Michel Chignard	8
5	Poly- l -Lysine Compacts DNA, Kills Bacteria, and Improves Protease Inhibition in Cystic Fibrosis Sputum 2013 ·American Journal of Respiratory and Critical Care Medicine ·Alice V. Dubois, Patrick Midoux, Delphine Gras, Mustapha Si‐Tahar, (unknown), Sylvie Attucci, (unknown), Reuben Ramphal, P. Diot, Francis Gauthier, Virginie Hervé	21
6	Lack of MyD88 Protects the Immunodeficient Host Against Fatal Lung Inflammation Triggered by the Opportunistic Bacteria Burkholderia cenocepacia 2009 ·The Journal of Immunology ·(unknown), Viviane Balloy, Reuben Ramphal, Huot Khun, Michel Huerre, Bernhard Ryffel, (unknown), Michel Chignard, Mustapha Si‐Tahar	20
7	Control of Pseudomonas aeruginosa in the Lung Requires the Recognition of Either Lipopolysaccharide or Flagellin 2008 ·The Journal of Immunology ·Reuben Ramphal, Viviane Balloy, Jeevan Jyot, Amrisha Verma, Mustapha Si‐Tahar, Michel Chignard	95
8	Neutrophil Elastase, an Innate Immunity Effector Molecule, Represses Flagellin Transcription in Pseudomonas aeruginosa 2006 ·Infection and Immunity ·Avinash Sonawane, Jeevan Jyot, (unknown), Reuben Ramphal	32
9	Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus 2006 ·Molecular Microbiology ·Jeevan Jyot, Avinash Sonawane, Weihui Wu, Reuben Ramphal	27
10	Importance of Adequate Initial Antimicrobial Therapy 2005 ·Chemotherapy ·Reuben Ramphal	43
11	Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients 2004 ·Proceedings of the National Academy of Sciences ·Matthew C. Wolfgang, Jeevan Jyot, Andrew L. Goodman, Reuben Ramphal, Stephen Lory	126
12	A POSITION PAPER ON THE TREATMENT OF HOSPITAL ACQUIRED PNEUMONIA (HAP): DO WE NEED GUIDELINES? 2002 ·Acta Clinica Belgica ·Reuben Ramphal	1
13	Evolution, Incidence, and Susceptibility of Bacterial Bloodstream Isolates from 519 Bone Marrow Transplant Patients 2001 ·Clinical Infectious Diseases ·(unknown), Helen Leather, John R. Wingard, Reuben Ramphal	221
14	In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997–1998 2000 ·International Journal of Antimicrobial Agents ·Ronald N. Jones, Stephen G. Jenkins, Daryl J. Hoban, Michael A. Pfaller, Reuben Ramphal	30
15	In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997–1998 2000 ·Diagnostic Microbiology and Infectious Disease ·Ronald N. Jones, Stephen G. Jenkins, Daryl J. Hoban, Michael A. Pfaller, Reuben Ramphal	20
16	1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever 1998 ·The Keio Journal of Medicine ·Reuben Ramphal	3
17	Recognition of Mucin by the Adhesin-Flagellar System of Pseudomonas aeruginosa 1996 ·American Journal of Respiratory and Critical Care Medicine ·Reuben Ramphal, Shiwani K. Arora, Bruce W. Ritchings	28
18	*Isolation and characterization of Pseudomonas aeruginosa* genes inducible by respiratory mucus derived from cystic fibrosis patients** 1996 ·Molecular Microbiology ·Jingyi Wang, Stephen Lory, Reuben Ramphal, Shouguang Jin	75
19	Malignant External Otitis: Report on Therapy with Ceftazidime and Review of Therapy and Prognosis 1990 ·Clinical Infectious Diseases ·Michael P. Johnson, Reuben Ramphal	35
20	Antibiotic review performed by a pharmacy and therapeutics subcommittee. 1982 ·PubMed ·(unknown), Reuben Ramphal	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact